INS and obesity disorder: The increase in irisin levels observed in obesity may simply be the result of an excessive adipose tissue as an important source of irisin, which may increase insulin sensitivity and energy expenditure as a compensatory mechanism to counteract the deleterious metabolic effects of excess adiposity, namely, insulin and catecholamine resistance [23, 64].